SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001694665-21-000047
Filing Date
2021-03-23
Accepted
2021-03-23 07:37:37
Documents
15
Period of Report
2021-03-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evlo-20210317.htm   iXBRL 8-K 45466
2 EX-1.1 exhibit11.htm EX-1.1 854178
  Complete submission text file 0001694665-21-000047.txt   1171621

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20210317.xsd EX-101.SCH 2424
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evlo-20210317_cal.xml EX-101.CAL 714
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evlo-20210317_def.xml EX-101.DEF 1651
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20210317_lab.xml EX-101.LAB 24975
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20210317_pre.xml EX-101.PRE 13191
8 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20210317_htm.xml XML 11198
Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38473 | Film No.: 21763160
SIC: 2834 Pharmaceutical Preparations